1. Home
  2. Middle East and North Africa
  3. Libya
  • News

US backs conversion of weapons plant to AIDS drug plant

The US has agreed to help Libya convert its Rabta chemical weapons plant near the capital, Tripoli, into a factory for drugs to treat AIDS, malaria and other infectious diseases. According to the Washington Times, the Executive Council of the Organisation for the Prohibition of Chemical Weapons this week approved "technical changes" to the global treaty on chemical arms to make the conversion possible. The Bush administration said it was "very supportive" of Libya and urged the council to endorse the plant's conversion "to produce low-cost pharmaceuticals to treat HIV/AIDS, malaria and tuberculosis, for use mainly in Africa." The State Department said, "The process of conversion and the facility, once converted, will be subject to international verification to ensure that no materials are misused for chemical weapons purposes."

This article was produced by IRIN News while it was part of the United Nations Office for the Coordination of Humanitarian Affairs. Please send queries on copyright or liability to the UN. For more information: https://shop.un.org/rights-permissions

Share this article

Get the day’s top headlines in your inbox every morning

Starting at just $5 a month, you can become a member of The New Humanitarian and receive our premium newsletter, DAWNS Digest.

DAWNS Digest has been the trusted essential morning read for global aid and foreign policy professionals for more than 10 years.

Government, media, global governance organisations, NGOs, academics, and more subscribe to DAWNS to receive the day’s top global headlines of news and analysis in their inboxes every weekday morning.

It’s the perfect way to start your day.

Become a member of The New Humanitarian today and you’ll automatically be subscribed to DAWNS Digest – free of charge.

Become a member of The New Humanitarian

Support our journalism and become more involved in our community. Help us deliver informative, accessible, independent journalism that you can trust and provides accountability to the millions of people affected by crises worldwide.

Join